Injectable Hemostat Composed of a Polyphosphate-Conjugated Hyaluronan Hydrogel.

We have developed a new hydrogel hemostat composed of hyaluronan (HA) conjugated with inorganic polyphosphate (PolyP). A hemostatic hydrogel, HAX-PolyP, was formed rapidly by mixing aldehyde-modified HA and hydrazide-modified HA conjugated with PolyP (HA-PolyP). Although the gelation rate decreased with increasing PolyP content, the gelation time was below 5 min. In addition, the hydrogel swelling volume decreased with increasing PolyP content, but the degradation rate did not depend on PolyP content and the hydrogel underwent complete degradation through hydrolysis over 3 weeks in phosphate buffered saline. HAX-PolyP showed similar biocompatibility with the HA hydrogel without PolyP conjugation in vitro and in vivo. Intraperitoneal administration of HAX-PolyP did not induce any adhesion in the peritoneum and clot formation in the lungs. Finally, HA-PolyP accelerated the coagulation rate of human plasma ex vivo, and HAX-PolyP showed as strong a hemostatic effect as fibrin glue in a mouse liver bleeding model in vivo.

[1]  Y. Liu,et al.  Artificial Dense Granules: A Procoagulant Liposomal Formulation Modeled after Platelet Polyphosphate Storage Pools. , 2016, Biomacromolecules.

[2]  K. Furukawa,et al.  Enhancing osteogenic differentiation of MC3T3-E1 cells by immobilizing inorganic polyphosphate onto hyaluronic acid hydrogel. , 2015, Biomacromolecules.

[3]  Y. Liu,et al.  Size-controlled synthesis of granular polyphosphate nanoparticles at physiologic salt concentrations for blood clotting. , 2014, Biomacromolecules.

[4]  Ali Khademhosseini,et al.  Surgical Materials: Current Challenges and Nano-enabled Solutions. , 2014, Nano today.

[5]  A. Khademhosseini,et al.  Shear-Thinning Nanocomposite Hydrogels for the Treatment of Hemorrhage , 2014, ACS nano.

[6]  S. Shono,et al.  Fibrinogen γ‐chain peptide‐coated, ADP‐encapsulated liposomes rescue thrombocytopenic rabbits from non‐compressible liver hemorrhage , 2012, Journal of thrombosis and haemostasis : JTH.

[7]  Stephanie A. Smith,et al.  Polyphosphate is a cofactor for the activation of factor XI by thrombin. , 2011, Blood.

[8]  Tae Gwan Park,et al.  Catechol-functionalized chitosan/pluronic hydrogels for tissue adhesives and hemostatic materials. , 2011, Biomacromolecules.

[9]  James H Morrissey,et al.  Polyphosphate exerts differential effects on blood clotting, depending on polymer size. , 2010, Blood.

[10]  H. Philippou,et al.  Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. , 2010, Blood.

[11]  R. Morishita,et al.  Inorganic polyphosphate differentiates human mesenchymal stem cells into osteoblastic cells , 2010, Journal of Bone and Mineral Metabolism.

[12]  T. Renné,et al.  Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo , 2009, Cell.

[13]  L. Martinelli,et al.  Use of CoSeal in a patient with a left ventricular assist device. , 2009, The Annals of thoracic surgery.

[14]  P. Gong,et al.  Effect of combined application of bFGF and inorganic polyphosphate on bioactivities of osteoblasts and initial bone regeneration. , 2009, Acta biomaterialia.

[15]  S. Moochhala,et al.  Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. , 2008, Biomaterials.

[16]  Y. Tomizawa,et al.  A simple hemostasis model for the quantitative evaluation of hydrogel-based local hemostatic biomaterials on tissue surface. , 2008, Colloids and surfaces. B, Biointerfaces.

[17]  S. Burks,et al.  Hemostats, sealants, and adhesives: components of the surgical toolbox , 2008, Transfusion.

[18]  James H Morrissey,et al.  Polyphosphate enhances fibrin clot structure. , 2007, Blood.

[19]  C. Highley,et al.  Dextran-based in situ cross-linked injectable hydrogels to prevent peritoneal adhesions. , 2007, Biomaterials.

[20]  C. Highley,et al.  The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives. , 2007, Biomaterials.

[21]  Kwok-Fai So,et al.  Nano hemostat solution: immediate hemostasis at the nanoscale. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[22]  Robert Langer,et al.  Peritoneal application of chitosan and UV-cross-linkable chitosan. , 2006, Journal of biomedical materials research. Part A.

[23]  R. Langer,et al.  In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. , 2006, Biomaterials.

[24]  A. Galembeck,et al.  Ionic transport in aluminum polyphosphate hydrogels , 2006 .

[25]  James H Morrissey,et al.  Polyphosphate modulates blood coagulation and fibrinolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Dayı,et al.  The Effect of Hyaluronic Acid-supplemented Bone Graft in Bone Healing: Experimental Study in Rabbits , 2006, Journal of biomaterials applications.

[27]  Mehmet C. Oz,et al.  Floseal Matrix: , 2003, Journal of cardiac surgery.

[28]  K. Shimamoto,et al.  Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  D. Hett,et al.  Sonoclot analysis. , 1995, British journal of anaesthesia.

[30]  E. Lima,et al.  Thermoreversible Gel Formation from Aqueous Aluminum Polyphosphate Solutions , 1994 .

[31]  P. Ness,et al.  Fibrin glue: the perfect operative sealant? , 1990, Transfusion.